<!doctype html><html lang=zh-tw><head><meta charset=utf-8><meta name=description content="at: [[inbox]]
Rheumatology - Inflammatory Myopathies - Fast Facts | NEJM Resident 360 Inflammatory, or immune-mediated, myopathies (IMM) are a group of systemic diseases characterized by autoimmunity, inflammation, muscle involvement, and often systemic features."><meta property="og:title" content><meta property="og:description" content><meta property="og:type" content="website"><meta property="og:url" content><meta property="og:image" content="https://og-ph6wrfvo1-htlin222.vercel.app/api/blog?templateTitle=Rheumatology - Inflammatory Myopathies - Fast Facts | NEJM Resident 360"><title>Rheumatology - Inflammatory Myopathies - Fast Facts | NEJM Resident 360</title><meta name=viewport content="width=device-width,initial-scale=1"><link rel=alternate type=application/rss+xml href=https://www.physician.tw//feed.xml title><link rel="shortcut icon" type=image/png href=https://www.physician.tw//icon.png><link href=https://www.physician.tw/styles.720e2c4835986a3891d6eef3a55faa22.min.css rel=stylesheet><link href=https://www.physician.tw/styles/_light_syntax.86a48a52faebeaaf42158b72922b1c90.min.css rel=stylesheet id=theme-link><script src=https://www.physician.tw/js/darkmode.dfadb738e747a87e78c7144d7267f1bc.min.js></script>
<script src=https://www.physician.tw/js/util.6f22941e242efae60fd84e7c32e874fa.min.js></script>
<link rel=preload href=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/katex.min.css as=style onload='this.onload=null,this.rel="stylesheet"' integrity=sha384-R4558gYOUz8mP9YWpZJjofhk+zx0AS11p36HnD2ZKj/6JR5z27gSSULCNHIRReVs crossorigin=anonymous><script defer src=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/katex.min.js integrity=sha384-z1fJDqw8ZApjGO3/unPWUPsIymfsJmyrDVWC8Tv/a1HeOtGmkwNd/7xUS0Xcnvsx crossorigin=anonymous></script>
<script defer src=https://cdn.jsdelivr.net/npm/katex@0.15.1/dist/contrib/auto-render.min.js integrity=sha384-+XBljXPPiv+OzfbB3cVmLHf4hdUFHlWNZN5spNQ7rmHTXpd7WvJum6fIACpNNfIR crossorigin=anonymous></script>
<script defer src=https://cdn.jsdelivr.net/npm/katex@0.16.2/dist/contrib/copy-tex.min.js integrity=sha384-ww/583aHhxWkz5DEVn6OKtNiIaLi2iBRNZXfJRiY1Ai7tnJ9UXpEsyvOITVpTl4A crossorigin=anonymous></script>
<script async src=https://unpkg.com/@floating-ui/core@0.7.3></script>
<script async src=https://unpkg.com/@floating-ui/dom@0.5.4></script>
<script async src=https://www.physician.tw/js/popover.f03552ccb84d99ca615d1cfb9abde59e.min.js></script>
<script defer src=https://www.physician.tw/js/code-title.ce4a43f09239a9efb48fee342e8ef2df.min.js></script>
<script defer src=https://www.physician.tw/js/clipboard.2913da76d3cb21c5deaa4bae7da38c9f.min.js></script>
<script defer src=https://www.physician.tw/js/callouts.7723cac461d613d118ee8bb8216b9838.min.js></script>
<script>const SEARCH_ENABLED=!1,LATEX_ENABLED=!0,PRODUCTION=!0,BASE_URL="https://www.physician.tw/",fetchData=Promise.all([fetch("https://www.physician.tw/indices/linkIndex.afe4548e6c13b682ece96b98cb7d656b.min.json").then(e=>e.json()).then(e=>({index:e.index,links:e.links})),fetch("https://www.physician.tw/indices/contentIndex.8bf4cd13a3cbdb4170020677cfd52d87.min.json").then(e=>e.json())]).then(([{index:e,links:t},n])=>({index:e,links:t,content:n})),render=()=>{const e=new URL(BASE_URL),t=e.pathname,n=window.location.pathname,s=t==n;addCopyButtons(),addTitleToCodeBlocks(),addCollapsibleCallouts(),initPopover("https://www.physician.tw",!0);const o=document.getElementById("footer");if(o){const e=document.getElementById("graph-container");if(!e)return requestAnimationFrame(render);e.textContent="";const t=s&&!1;drawGraph("https://www.physician.tw",t,[{"/moc":"#4388cc"}],t?{centerForce:1,depth:-1,enableDrag:!0,enableLegend:!1,enableZoom:!0,fontSize:.5,linkDistance:1,opacityScale:3,repelForce:1,scale:1.4}:{centerForce:1,depth:1,enableDrag:!0,enableLegend:!1,enableZoom:!0,fontSize:.6,linkDistance:1,opacityScale:3,repelForce:2,scale:1.2})}},init=(e=document)=>{addCopyButtons(),addTitleToCodeBlocks(),renderMathInElement(e.body,{delimiters:[{left:"$$",right:"$$",display:!0},{left:"$",right:"$",display:!1}],macros:{'’':"'"},throwOnError:!1})}</script><script type=module>
    import { attachSPARouting } from "https:\/\/www.physician.tw\/js\/router.9d4974281069e9ebb189f642ae1e3ca2.min.js"
    attachSPARouting(init, render)
  </script></head><body><div id=search-container><div id=search-space><input autocomplete=off id=search-bar name=search type=text aria-label=搜尋 placeholder="請輸入像是：hypertension 之類的來看沒有沒什麼有趣的🎳"><div id=results-container></div></div></div><script src=https://cdn.jsdelivr.net/npm/flexsearch@0.7.21/dist/flexsearch.bundle.js integrity="sha256-i3A0NZGkhsKjVMzFxv3ksk0DZh3aXqu0l49Bbh0MdjE=" crossorigin=anonymous defer></script>
<script defer src=https://www.physician.tw/js/full-text-search.e6e2e0c213187ca0c703d6e2c7a77fcd.min.js></script><div class=singlePage><header><h1 id=page-title><a href=https://www.physician.tw/>蜥蜴花園🦎🌱🪴🌲</a></h1><div class=spacer></div><div id=search-icon><p>搜尋</p><svg tabindex="0" aria-labelledby="title desc" role="img" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 19.9 19.7"><title id="title">搜尋圖示</title><desc id="desc">打開搜尋圖標</desc><g class="search-path" fill="none"><path stroke-linecap="square" d="M18.5 18.3l-5.4-5.4"/><circle cx="8" cy="8" r="7"/></g></svg></div><div class=darkmode><input class=toggle id=darkmode-toggle type=checkbox tabindex=-1>
<label id=toggle-label-light for=darkmode-toggle tabindex=-1><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" id="dayIcon" viewBox="0 0 35 35" style="enable-background:new 0 0 35 35"><title>明亮模式</title><path d="M6 17.5C6 16.672 5.328 16 4.5 16h-3C.672 16 0 16.672.0 17.5S.672 19 1.5 19h3C5.328 19 6 18.328 6 17.5zM7.5 26c-.414.0-.789.168-1.061.439l-2 2C4.168 28.711 4 29.086 4 29.5 4 30.328 4.671 31 5.5 31c.414.0.789-.168 1.06-.44l2-2C8.832 28.289 9 27.914 9 27.5 9 26.672 8.329 26 7.5 26zm10-20C18.329 6 19 5.328 19 4.5v-3C19 .672 18.329.0 17.5.0S16 .672 16 1.5v3C16 5.328 16.671 6 17.5 6zm10 3c.414.0.789-.168 1.06-.439l2-2C30.832 6.289 31 5.914 31 5.5 31 4.672 30.329 4 29.5 4c-.414.0-.789.168-1.061.44l-2 2C26.168 6.711 26 7.086 26 7.5 26 8.328 26.671 9 27.5 9zM6.439 8.561C6.711 8.832 7.086 9 7.5 9 8.328 9 9 8.328 9 7.5c0-.414-.168-.789-.439-1.061l-2-2C6.289 4.168 5.914 4 5.5 4 4.672 4 4 4.672 4 5.5c0 .414.168.789.439 1.06l2 2.001zM33.5 16h-3c-.828.0-1.5.672-1.5 1.5s.672 1.5 1.5 1.5h3c.828.0 1.5-.672 1.5-1.5S34.328 16 33.5 16zM28.561 26.439C28.289 26.168 27.914 26 27.5 26c-.828.0-1.5.672-1.5 1.5.0.414.168.789.439 1.06l2 2C28.711 30.832 29.086 31 29.5 31c.828.0 1.5-.672 1.5-1.5.0-.414-.168-.789-.439-1.061l-2-2zM17.5 29c-.829.0-1.5.672-1.5 1.5v3c0 .828.671 1.5 1.5 1.5s1.5-.672 1.5-1.5v-3C19 29.672 18.329 29 17.5 29zm0-22C11.71 7 7 11.71 7 17.5S11.71 28 17.5 28 28 23.29 28 17.5 23.29 7 17.5 7zm0 18c-4.136.0-7.5-3.364-7.5-7.5s3.364-7.5 7.5-7.5 7.5 3.364 7.5 7.5S21.636 25 17.5 25z"/></svg></label><label id=toggle-label-dark for=darkmode-toggle tabindex=-1><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" id="nightIcon" viewBox="0 0 100 100" style="enable-background='new 0 0 100 100'"><title>黑暗模式</title><path d="M96.76 66.458c-.853-.852-2.15-1.064-3.23-.534-6.063 2.991-12.858 4.571-19.655 4.571C62.022 70.495 50.88 65.88 42.5 57.5 29.043 44.043 25.658 23.536 34.076 6.47c.532-1.08.318-2.379-.534-3.23-.851-.852-2.15-1.064-3.23-.534-4.918 2.427-9.375 5.619-13.246 9.491-9.447 9.447-14.65 22.008-14.65 35.369.0 13.36 5.203 25.921 14.65 35.368s22.008 14.65 35.368 14.65c13.361.0 25.921-5.203 35.369-14.65 3.872-3.871 7.064-8.328 9.491-13.246C97.826 68.608 97.611 67.309 96.76 66.458z"/></svg></label></div></header><article><h1>Rheumatology - Inflammatory Myopathies - Fast Facts | NEJM Resident 360</h1><p class=meta>最後更新於
Feb 23, 2023
<a href=https://github.com/htlin222/garden/tree/hugo/content/Rheumatology%20-%20Inflammatory%20Myopathies%20-%20Fast%20Facts%20%20NEJM%20Resident%20360.md rel=noopener>🪚 編輯原始文件</a></p><ul class=tags></ul><p>at: <a href=/inbox rel=noopener class=internal-link data-src=/inbox>inbox</a></p><a href=#rheumatology---inflammatory-myopathies---fast-facts--nejm-resident-360><h1 id=rheumatology---inflammatory-myopathies---fast-facts--nejm-resident-360><span class=hanchor arialabel=Anchor># </span>Rheumatology - Inflammatory Myopathies - Fast Facts | NEJM Resident 360</h1></a><p>Inflammatory, or immune-mediated, myopathies (IMM) are a group of systemic diseases characterized by autoimmunity, inflammation, muscle involvement, and often systemic features. The hallmark of inflammatory myositis is painless muscle weakness, though myalgia can be experienced. Fibromyalgia is covered in the Ambulatory Care rotation guide.</p><p>The four subtypes of inflammatory myopathies are:</p><ul><li><p>dermatomyositis (DM)</p></li><li><p>polymyositis (PM)</p></li><li><p>necrotizing autoimmune myositis (NAM)</p></li><li><p>inclusion body myositis (IBM)</p></li></ul><a href=#diagnosis><h3 id=diagnosis><span class=hanchor arialabel=Anchor># </span>Diagnosis</h3></a><p>Immune-mediated myopathies should be considered as a differential diagnosis in all cases of elevated serum creatine kinase, in patients reporting weakness or myalgia, and in patients with suggestive skin findings. In addition, myopathy (inflammatory or otherwise) should be considered in patients with abnormal liver function tests, particularly when the aspartate aminotransferase is greater than the alanine aminotransferase.</p><p>Differentiating the types of IMM requires correlation of clinical and MRI findings with the autoantibody profile (if detected), and histologic and immunohistochemical features of the affected muscle tissue.</p><p>Distribution of affected muscles and associated features differs for each subtype and is outlined in the following table:</p><a href=#symptoms-associated-with-subtypes-of-inflammatory-myopathy><h3 id=symptoms-associated-with-subtypes-of-inflammatory-myopathy><span class=hanchor arialabel=Anchor># </span>Symptoms Associated with Subtypes of Inflammatory Myopathy</h3></a><table><thead><tr><th></th><th>Dermatomyositis</th><th>Polymyositis</th><th>Necrotising Autoimmune Myositis</th><th>Inclusion Body Myositis</th></tr></thead><tbody><tr><td><em><strong>Muscle Group Affected</strong></em></td><td></td><td></td><td></td><td></td></tr><tr><td>Proximal</td><td>✔</td><td>✔</td><td>✔</td><td>✔</td></tr><tr><td>Distal</td><td></td><td></td><td></td><td>✔</td></tr><tr><td>Facial</td><td></td><td></td><td></td><td>✔</td></tr><tr><td>Neck/pharynx</td><td></td><td></td><td></td><td></td></tr><tr><td>(dysphagia)</td><td>✔</td><td>✔</td><td>✔</td><td>✔</td></tr><tr><td>Symmetry of weakness</td><td>Symmetrical</td><td>Symmetrical</td><td>Symmetrical</td><td>Asymmetrical</td></tr><tr><td><em><strong>Associated Features</strong></em></td><td></td><td></td><td></td><td></td></tr><tr><td>Antisynthetase syndrome, consisting of:</td><td></td><td></td><td></td><td></td></tr></tbody></table><ul><li>myositis</li><li>interstitial lung disease</li><li>Raynaud phenomenon</li><li>arthritis</li><li>mechanic’s hand rash</li><li>anti-RNA and anti-Jo1 antibodies | ✔ | ✔ | ✔ | |
| Gottron papules | ✔ | | | |
| Heliotrope rash | ✔ | | | |
| Photodistributed rash:</li><li>shawl sign, involving the back</li><li>V sign, over the neck and upper chest | ✔ | | | |
| Interstitial lung disease | ✔ | ✔ | | |</li></ul><p><strong>Workup:</strong></p><ul><li><p>History and physical examination:</p><ul><li><p>statin exposure</p></li><li><p>concomitant autoimmune diseases or inflammatory arthritis</p></li><li><p>distribution and involvement of muscle weakness</p></li><li><p>cutaneous manifestations for DM and antisynthetase syndrome</p></li><li><p>pulmonary manifestations</p></li><li><p>features suggestive of malignancy</p></li></ul></li><li><p>Serology and biochemistry:</p><ul><li><p>creatine kinase, alanine and aspartate aminotransferases, lactate dehydrogenase (all are typically elevated with muscle inflammation); aldolase measurement is not routinely needed</p></li><li><p>antinuclear antibodies, anti-Ro and anti-La antibodies, myositis-specific antibodies (including HMG-CoA antibodies)</p></li></ul></li><li><p>MRI is the best imaging modality for inflammatory myopathy and should include:</p><ul><li><p>bilateral limbs to assess for distribution of muscle inflammation and aid target for biopsy</p></li><li><p>a fat-suppressed MRI sequence to assess for muscle inflammation</p></li><li><p>in the right clinical context, muscle edema may indicate active disease but the specificity of this finding for myositis may be limited; muscle atrophy and fatty replacement suggest muscle damage without disease activity</p></li></ul></li><li><p>Tissue biopsy is the gold-standard diagnostic test, performed where active disease is identified; however, as the lower limbs are frequently affected, “blind” biopsies of the vastus lateralis muscle can be performed.</p><ul><li>Tissue should be analyzed for histologic, immunohistochemical, and electron microscopic features that aid in differentiating various muscle diseases (i.e., IMM vs. muscular degeneration vs. mitochondrial disorders).</li></ul></li><li><p>Additional investigations may be performed to assess for extramuscular involvement if indicated (e.g., interstitial lung disease, cardiac involvement, malignancy).</p></li></ul><p>The following chart summarizes the diagnostic approach for each of the four subtypes of inflammatory myopathies:</p><p><strong>(Source: Inflammatory Muscle Diseases. N Engl J Med 2015.)</strong> </p><p><strong>Differential diagnosis:</strong> An important differential diagnosis in some patients who take statins is statin-associated autoimmune myopathy. Some patients taking statins may develop myalgias, cramps, and occasionally elevated levels of creatinine kinase (CK) that resolve with statin discontinuation. A minority of patients exposed to statins develop antibodies against 3-hydroxy-3-methyl-glutaryl–coenzyme A reductase (HMGCR) and necrotizing myopathy that requires immunosuppression.</p><p>Inflammatory myopathy can also be seen in other autoimmune conditions such as sarcoidosis, polyarteritis nodosa, systemic lupus erythematosus, mixed connective tissue disease, and overlap syndromes.</p><p><strong>Evaluation for malignancy:</strong> Patients with DM, and to a lesser extent PM, have a higher risk for malignancy than the general population. No specific guidelines exist for malignancy workup, and routine whole-body CT (informally, “pan scans”) or even positron emission tomography are not specifically recommended. However, many clinicians perform pan scanning, especially for adult patients with dermatomyositis (rather than another myopathy) or those with certain autoantibodies (including anti–transcriptional intermediary factor 1γ, antinuclear matrix protein-2). Age-appropriate cancer-screening guidelines should be followed, and any additional workup should be performed if clinically indicated. </p><a href=#treatment><h3 id=treatment><span class=hanchor arialabel=Anchor># </span>Treatment</h3></a><p>Treatment for DM, PM, and NAM generally involves immunosuppression: Glucocorticoids are first-line treatment. Currently, there is no reliably effective therapy for IBM. The following table details the treatment algorithm for DM, PM, and NAM.</p><p><strong>(Source: Inflammatory Muscle Diseases. N Engl J Med 2015.)</strong></p><p><a href=/inbox rel=noopener class=internal-link data-src=/inbox>inbox</a></p></article><hr><div class=page-end id=footer><div class=backlinks-container><h3>↩️ 反向連結</h3><ul class=backlinks><li><a href=/all-list-of-resident360/ data-ctx="Rheumatology - Inflammatory Myopathies - Fast Facts  NEJM Resident 360" data-src=/all-list-of-resident360 class=internal-link>all list of resident360</a></li><li><a href=/rheum/ data-ctx="Rheumatology - Inflammatory Myopathies - Fast Facts  NEJM Resident 360" data-src=/rheum class=internal-link>rheumatology</a></li><li><a href=/rheumatology/ data-ctx="Rheumatology - Inflammatory Myopathies - Fast Facts  NEJM Resident 360" data-src=/rheumatology class=internal-link>rheumatology</a></li></ul></div><div><script async src=https://cdn.jsdelivr.net/npm/d3@6.7.0/dist/d3.min.js integrity="sha256-+7jaYCp29O1JusNWHaYtgUn6EhuP0VaFuswhNV06MyI=" crossorigin=anonymous></script><h3>🤯互動圖</h3><div id=graph-container></div><style>:root{--g-node:var(--secondary);--g-node-active:var(--primary);--g-node-inactive:var(--visited);--g-link:var(--outlinegray);--g-link-active:#5a7282}</style><script src=https://www.physician.tw/js/graph.2d9e48dbe7ea47c0ef1c58296ce14448.js></script></div><div><div id=disqus_thread></div><script type=application/javascript>window.disqus_config=function(){},function(){if(["localhost","127.0.0.1"].indexOf(window.location.hostname)!=-1){document.getElementById("disqus_thread").innerHTML="Disqus comments not available by default when the website is previewed locally.";return}var t=document,e=t.createElement("script");e.async=!0,e.src="//physician.disqus.com/embed.js",e.setAttribute("data-timestamp",+new Date),(t.head||t.body).appendChild(e)}()</script><noscript>Please enable JavaScript to view the <a href=https://disqus.com/?ref_noscript>comments powered by Disqus.</a></noscript><a href=https://disqus.com class=dsq-brlink>comments powered by <span class=logo-disqus>Disqus</span></a></div></div><div id=contact_buttons><footer><p>本網站是由 Hsieh-Ting Lin 以❤️ 用 <a href=https://github.com/jackyzha0/quartz>Quartz</a>這個酷東西種出來🪴 , © 2023</p><p><a href=https://www.buymeacoffee.com/htl.lizard><img src=https://cdn.buymeacoffee.com/buttons/v2/default-yellow.png width=200></a></p><ul><li><a href=https://www.physician.tw/>🏠首頁</a></li><li><a href=https://www.facebook.com/Tim.H.Lin>Facebook</a></li><li><a href=https://twitter.com/htlin222>Twitter</a></li><li><a href=https://github.com/htlin222>GitHub</a></li><li><a href=https://htlin.site>Blog</a></li><li><a href=https://medium.com/@hsieh-ting-lin>Medium</a></li></ul></footer></div></div></body></html>